Need to find a specific expert or member of a research group or division? Just search by role, division, name or browse our researchers A-Z.

Patients and members of the public are vital to our research. Without patients choosing to taking part in our clinical trials our research would not be possible. We also have patients advising us on ...

Advocacy engagement: policy and public affairs Our policy priorities Creating a sustainable funding model for research in universities Encouraging international talent to support cancer research ...

A blood test can predict how well patients with advanced breast cancer will respond to targeted therapies – before treatment begins, according to new research. A team from The Institute of Cancer ...

The Institute of Cancer Research, London has welcomed the announcement by NHS England that the lifesaving drug abiraterone has been approved for use on the NHS for men in England with prostate cancer ...

New research presents clear guidelines on how patient-reported outcomes (PROs) can be used more effectively in early-stage cancer drug trials, helping ensure that patient experiences meaningfully ...

As we enter 2026, scientists at The Institute of Cancer Research, London, share the developments expected this year that could soon change how cancer is treated – from technologies designed to deliver ...

Peter Laing was diagnosed in November 2024, with stage 2/3b high-risk prostate cancer. Now retired, his former career in the biotech industry has helped to inform decisions about his treatment, which ...